Stockscreener 앱 받기
0.8104
3.52%
-0.0296
전일 마감가:
$0.84
열려 있는:
$0.8165
하루 거래량:
51,462
Relative Volume:
0.17
시가총액:
$62.28M
수익:
$9.53M
순이익/손실:
$-44.61M
주가수익비율:
-0.8905
EPS:
-0.91
순현금흐름:
$-38.32M
1주 성능:
+0.25%
1개월 성능:
-8.21%
6개월 성능:
-34.65%
1년 성능:
+11.15%
1일 변동 폭
$0.80
$0.8408
1주일 범위
$0.78
$0.8873
52주 변동 폭
$0.45
$1.9891
Cue Biopharma Inc Stock (CUE) Company Profile
명칭
Cue Biopharma Inc
전화
617-949-2680
주소
40 GUEST STREET, BOSTON, MA
CUE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CUE
Cue Biopharma Inc
|
0.8104 | 62.88M | 9.53M | -44.61M | -38.32M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.21 | 99.72B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
587.96 | 60.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.30 | 58.15B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
703.54 | 41.45B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
299.80 | 36.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-13 | 개시 | Jefferies | Buy |
| 2023-06-26 | 재개 | Oppenheimer | Outperform |
| 2022-11-21 | 개시 | Piper Sandler | Overweight |
| 2022-01-13 | 개시 | H.C. Wainwright | Buy |
| 2022-01-03 | 개시 | Craig Hallum | Buy |
| 2020-11-24 | 개시 | Berenberg | Buy |
| 2020-04-09 | 개시 | Stifel | Buy |
| 2020-01-28 | 개시 | BTIG Research | Buy |
| 2020-01-22 | 개시 | JMP Securities | Mkt Outperform |
모두보기
Cue Biopharma Inc 주식(CUE)의 최신 뉴스
Real time scanner hits for Cue Biopharma Inc. explainedWeekly Trade Analysis & Consistent Profit Trade Alerts - Newser
Cue Biopharma Inc. Recovery Likely Here’s What Data Shows getLinesFromResByArray error: size == 0 - 더경남뉴스
Cue Biopharma Inc. stock trend forecastJuly 2025 Institutional & High Win Rate Trade Tips - Newser
Will Cue Biopharma Inc. stock benefit from interest rate changesQuarterly Portfolio Report & Reliable Price Breakout Alerts - Newser
Why Cue Biopharma Inc. stock is on top investor watchlistsWeekly Risk Summary & Step-by-Step Trade Execution Guides - Newser
What makes Cue Biopharma Inc. stock price move sharply2025 Investor Takeaways & Daily Entry Point Trade Alerts - Newser
Is Cue Biopharma Inc. meeting your algorithmic filter criteriaWeekly Risk Summary & Safe Entry Momentum Stock Tips - Newser
Is Cue Biopharma Inc. stock entering bullish territoryForecast Cut & Advanced Technical Analysis Signals - Newser
Analyzing recovery setups for Cue Biopharma Inc. investorsMarket Performance Report & AI Forecast for Swing Trade Picks - Newser
Will Cue Biopharma Inc. bounce back from current supportJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - Newser
Does Cue Biopharma Inc. fit your quant trading modelEarnings Risk Summary & Growth Focused Stock Reports - Newser
Predicting Cue Biopharma Inc. trend using moving averagesWatch List & Verified Momentum Stock Alerts - Newser
How to recover losses in Cue Biopharma Inc. stockTrade Performance Summary & Precise Buy Zone Tips - Newser
Applying sector rotation models to Cue Biopharma Inc.Breakout Watch & Risk Controlled Swing Trade Alerts - Newser
Has Cue Biopharma Inc. found a price floor2025 Bull vs Bear & Daily Entry Point Trade Alerts - Newser
Lucid Capital Initiates Cue Biopharma with Buy Rating and $4 Price Target. - AInvest
Lucid Capital Markets Initiates Coverage on Cue Biopharma with 'Buy' Rating and $4.00 Price Target - AInvest
Cue Biopharma stock initiated with Buy rating at Lucid Capital Markets - Investing.com Canada
Cue Biopharma Inc. stock daily chart insightsTrade Risk Assessment & Consistent Income Trade Recommendations - Newser
Earnings visualization tools for Cue Biopharma Inc.July 2025 Trade Ideas & Technical Entry and Exit Alerts - Newser
Cue Biopharma: Lucid Capital Markets initiates Buy coverage with PT $4 - AInvest
When is the best time to exit Cue Biopharma Inc.2025 Top Gainers & Expert Curated Trade Setups - Newser
Cue Biopharma Inc. Approaches Psychological Resistance LevelAnalyst Downgrade & Real-Time Stock Movement Alerts - 클래시안
Is Cue Biopharma Inc. forming a bottoming baseGold Moves & Verified Momentum Stock Alerts - Newser
Can Cue Biopharma Inc. expand its profit marginsPortfolio Growth Summary & Smart Swing Trading Alerts - theviewers.co.kr
Regression analysis insights on Cue Biopharma Inc. performance2025 Market Outlook & Capital Efficient Trade Techniques - Newser
What is Cue Biopharma Inc. s revenue forecastQuarterly Trade Summary & Safe Entry Zone Identification - theviewers.co.kr
How Cue Biopharma Inc. stock performs during market volatilityMarket Growth Summary & Precise Swing Trade Alerts - Newser
Is Cue Biopharma Inc. stock a good pick for beginners2025 Market Outlook & Low Volatility Stock Recommendations - theviewers.co.kr
Macro Review: Should I add Cue Biopharma Inc. stock to my portfolioWeekly Market Report & Technical Entry and Exit Alerts - theviewers.co.kr
Short interest data insights for Cue Biopharma Inc.July 2025 Big Picture & Low Risk High Win Rate Stock Picks - Newser
Is Cue Biopharma Inc. the Top Chart Pick This Week2025 Macro Impact & Weekly Watchlist of Top Performers - beatles.ru
Cue Biopharma Inc. Hits Price Floor — Bounce IncomingJuly 2025 Summary & Step-by-Step Swing Trade Plans - kangso.co.kr
Cue Biopharma shares rise 6.17% premarket after announcing participation in Cantor Global Healthcare Conference. - AInvest
Cue Biopharma Inc. Recovery Likely Here’s What Data ShowsWeekly Trading Summary & Free Real-Time Volume Trigger Notifications - beatles.ru
Cue Biopharma to Participate in Fireside Chat at the Cantor Glob - GuruFocus
Cue Biopharma to Present Program Updates at Cantor Global Healthcare Conference 2025 - Quiver Quantitative
Cue Biopharma to Participate in Fireside Chat at the Cantor Global Healthcare Conference - The Manila Times
Cue Biopharma to Discuss CUE-401 Advances at Cantor Global Healthcare Conference - AInvest
Cue Biopharma to Present at Cantor Global Healthcare Conference - AInvest
Biotech Innovation: Cue Biopharma to Showcase Novel T-Cell Platform at Major Healthcare Conference - Stock Titan
Evaluating Cue Biopharma Inc. with trendline analysisWeekly Trade Recap & Verified Momentum Watchlists - Newser
Using AI based signals to follow Cue Biopharma Inc.Market Rally & Daily Stock Trend Watchlist - Newser
Cue Biopharma’s Q2 2025: Strategic Advances and Financial Highlights - TipRanks
Cue Biopharma Inc (CUE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.53%
7.14%
자본화:
|
볼륨(24시간):